Literature DB >> 1531290

A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

M Diener-West1, B S Hawkins, J A Markowitz, A P Schachat.   

Abstract

With the use of data published during the period from 1966 through 1988, a pooled analysis (meta-analysis) of 5-year mortality rates among patients who had an eye enucleated for choroidal melanoma was performed to provide a more robust estimate of this rate than could be obtained from any single study. The literature concerning mortality following a diagnosis of choroidal melanoma has been reviewed systematically and described in a separate article. Of 76 reports published from 1966 through 1988, 29 were excluded from the meta-analysis because there were no cases treated by enucleation alone, mortality was not reported by time from enucleation, fewer than 10 cases were reported, or 5-year mortality rates were not reported or derivable from the data presented. Ten additional reports were excluded because they were based on data for the same set of patients as another article in the series. Of the remaining 37 reports, 29 contained data for patients with tumors of varying sizes that could not be separated into subgroups based on the size of the tumor at the time of treatment. The remaining eight articles reported 5-year mortality rates by tumor size, specifically for small, medium, or large tumors. The combined weighted estimates of 5-year mortality rates following enucleation were 16% for small tumors (95% confidence interval [CI]: [14%, 18%]), 32% for medium tumors (95% CI: [29%, 34%]), and 53% for large tumors (95% CI: [50%, 56%]). Different methods of pooling the data yielded consistent estimates for all three tumor size categories.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1992        PMID: 1531290     DOI: 10.1001/archopht.1992.01080140101036

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  65 in total

1.  Digital imaging in differential diagnosis of small choroidal melanoma.

Authors:  Jukka M Saari; Tero Kivelä; Paula Summanen; Kari Nummelin; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  Whole body PET/CT imaging for detection of metastatic choroidal melanoma.

Authors:  P T Finger; M Kurli; P Wesley; L Tena; K R Kerr; A Pavlick
Journal:  Br J Ophthalmol       Date:  2004-08       Impact factor: 4.638

Review 3.  Don't it make my blue eyes brown: heterochromia and other abnormalities of the iris.

Authors:  I G Rennie
Journal:  Eye (Lond)       Date:  2011-10-07       Impact factor: 3.775

4.  Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.

Authors:  Brandon T Nguyen; Ryan S Kim; Maria E Bretana; Eric Kegley; Amy C Schefler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-28       Impact factor: 3.117

5.  Visual Outcome and Millimeter Incremental Risk of Metastasis in 1780 Patients With Small Choroidal Melanoma Managed by Plaque Radiotherapy.

Authors:  Carol L Shields; Kareem Sioufi; Archana Srinivasan; Maura Di Nicola; Babak Masoomian; Laura E Barna; Vladislav P Bekerman; Emil A T Say; Arman Mashayekhi; Jacqueline Emrich; Lydia Komarnicky; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

6.  Prognostic relevance of ATM protein in uveal melanoma and its association with clinicopathological factors.

Authors:  Jayanti Jha; Mithalesh Kumar Singh; Lata Singh; Neelam Pushker; Mandeep Singh Bajaj; Seema Sen; Seema Kashyap
Journal:  Int J Clin Oncol       Date:  2019-08-03       Impact factor: 3.402

7.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

8.  Risk factors for metastatic uveal melanoma after trans-scleral local resection.

Authors:  B E Damato; J Paul; W S Foulds
Journal:  Br J Ophthalmol       Date:  1996-02       Impact factor: 4.638

9.  Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.

Authors:  X Q Huang; M S Mitchell; P E Liggett; A L Murphree; J Kan-Mitchell
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

10.  Genetics of uveal melanoma and cutaneous melanoma: two of a kind?

Authors:  Thomas van den Bosch; Emine Kilic; Dion Paridaens; Annelies de Klein
Journal:  Dermatol Res Pract       Date:  2010-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.